Exhibit 99.2
Unaudited Pro Forma Financial Statements
The following Unaudited Pro Forma Financial Statements are based on the Company’s historical consolidated results of operations and financial position, adjusted to give effect to the Transaction, as defined in Item 2.01 of this Form 8-K, as if it had been completed on March 31, 2017 with respect to the pro forma condensed balance sheet and as of January 1, 2016 with respect to the pro forma condensed statements of operations.
The Unaudited Pro Forma Financial Statements and the accompanying notes should be read together with the Company’s audited consolidated financial statements and accompanying notes as of and for the year ended December 31, 2016, and Management’s Discussion and Analysis of Financial Condition and Results of Operations included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2016 (“Annual Report”) and its unaudited condensed consolidated financial statements and accompanying notes as of and for the three months ended March 31, 2017 and Management’s Discussion and Analysis of Financial Condition and Results of Operations included in the Company's Quarterly Report on Form 10-Q ("Quarterly Report") for the three months ended March 31, 2017. The Unaudited Pro Forma Financial Statements may differ materially from the future financial position or results of operations due to a number of factors described in “Risk Factors” under Item 1A of Part 1 of our Annual Report and “Forward-Looking Statements” under Item 1 of Part 1 of our Annual Report.
1
Tenet Healthcare Corporation
Unaudited Pro Forma Condensed Balance Sheet
March 31, 2017
| Historical | Pro Forma Adjustments | Pro Forma | ||||||||||||
| ASSETS | ||||||||||||||
| Current assets: | ||||||||||||||
| Cash and cash equivalents | $ | 572 | $ | 755 | (a) | $ | 1,327 | |||||||
| Accounts receivable, less allowance for doubtful accounts | 2,960 | (112 | ) | (a) | 2,848 | |||||||||
| Inventories of supplies, at cost | 324 | (9 | ) | (a) | 315 | |||||||||
| Income tax receivable | 26 | (8 | ) | (a) | 18 | |||||||||
| Assets held for sale | 3 | 3 | ||||||||||||
| Other current assets | 1,167 | (9 | ) | (a) | 1,158 | |||||||||
| Total current assets | 5,052 | 617 | 5,669 | |||||||||||
| Investments and other assets | 1,260 | (4 | ) | (a) | 1,256 | |||||||||
| Deferred income taxes | 930 | (140 | ) | (a) | 790 | |||||||||
| Property and equipment, at cost, less accumulated depreciation and amortization | 7,976 | (209 | ) | (a) | 7,767 | |||||||||
| Goodwill | 7,429 | (310 | ) | (a) | 7,119 | |||||||||
| Other intangible assets, at cost, less accumulated amortization | 1,863 | (37 | ) | (a) | 1,826 | |||||||||
Total assets | $ | 24,510 | $ | (83 | ) | $ | 24,427 | |||||||
| LIABILITIES AND EQUITY | ||||||||||||||
| Current liabilities: | ||||||||||||||
| Current portion of long-term debt | $ | 147 | $ | (1 | ) | (a) | $ | 146 | ||||||
| Accounts payable | 1,179 | (14 | ) | (a) | 1,165 | |||||||||
| Accrued compensation and benefits | 739 | (11 | ) | (a) | 728 | |||||||||
| Professional and general liability reserves | 201 | 201 | ||||||||||||
| Accrued interest payable | 327 | 327 | ||||||||||||
| Liabilities held for sale | — | — | ||||||||||||
| Accrued legal settlement costs | 11 | 11 | ||||||||||||
| Other current liabilities | 1,163 | (7 | ) | (a) | 1,156 | |||||||||
| Total current liabilities | 3,767 | (33 | ) | 3,734 | ||||||||||
| Long-term debt, net of current portion | 15,071 | (1 | ) | (a) | 15,070 | |||||||||
| Professional and general liability reserves | 614 | 614 | ||||||||||||
| Defined benefit plan obligations | 624 | 624 | ||||||||||||
| Deferred income taxes | 289 | 289 | ||||||||||||
| Other long-term liabilities | 621 | (1 | ) | (a) | 620 | |||||||||
| Total liabilities | 20,986 | (35 | ) | 20,951 | ||||||||||
| Commitments and contingencies | ||||||||||||||
| Redeemable noncontrolling interests in equity of consolidated subsidiaries | 2,430 | 2,430 | ||||||||||||
| Equity: | ||||||||||||||
| Shareholders’ equity: | ||||||||||||||
| Common stock | 7 | 7 | ||||||||||||
| Additional paid-in capital | 4,834 | 4,834 | ||||||||||||
| Accumulated other comprehensive loss | (255 | ) | (255 | ) | ||||||||||
| Accumulated deficit | (1,739 | ) | (33 | ) | (a) | (1,772 | ) | |||||||
| Common stock in treasury, at cost | (2,417 | ) | (2,417 | ) | ||||||||||
| Total shareholders’ equity | 430 | (33 | ) | 397 | ||||||||||
| Noncontrolling interests | 664 | (15 | ) | (a) | 649 | |||||||||
| Total equity | 1,094 | (48 | ) | 1,046 | ||||||||||
| Total liabilities and equity | $ | 24,510 | $ | (83 | ) | $ | 24,427 | |||||||
2
Notes to Unaudited Pro Forma
Condensed Balance Sheet
| (a) | Records the proceeds from the sale of the Houston-area hospitals and related facilities, derecognition of the related assets and liabilities and noncontrolling interests, and the related after-tax loss on sale, using an effective rate of 37%, which includes the federal statutory rate of 35% and the applicable state taxes, adjusted for the impact of nondeductible goodwill. |
3
Tenet Healthcare Corporation
Unaudited Pro Forma Condensed Statement of Operations
For the Year Ended December 31, 2016
| (Dollars in millions except per share amounts) | Historical | Pro Forma Adjustments | Pro Forma | |||||||||||
| Net operating revenues: | ||||||||||||||
| Net operating revenues before provision for doubtful accounts | $ | 21,070 | $ | (712 | ) | (a) | $ | 20,358 | ||||||
| Less: Provision for doubtful accounts | 1,449 | (133 | ) | (a) | 1,316 | |||||||||
Net operating revenues | 19,621 | (579 | ) | 19,042 | ||||||||||
| Equity in earnings of unconsolidated affiliates | 131 | 131 | ||||||||||||
| Operating expenses: | ||||||||||||||
| Salaries, wages and benefits | 9,356 | (247 | ) | (a) | 9,109 | |||||||||
| Supplies | 3,124 | (76 | ) | (a) | 3,048 | |||||||||
| Other operating expenses, net | 4,891 | (181 | ) | (a) | 4,710 | |||||||||
| Electronic health record incentives | (32 | ) | 2 | (a) | (30 | ) | ||||||||
| Depreciation and amortization | 850 | (21 | ) | (a) | 829 | |||||||||
| Impairment and restructuring charges, and acquisition-related costs | 202 | 202 | ||||||||||||
| Litigation and investigation costs | 293 | 293 | ||||||||||||
| Gains on sales, consolidation and deconsolidation of facilities | (151 | ) | (151 | ) | ||||||||||
| Operating income | 1,219 | (56 | ) | 1,163 | ||||||||||
| Interest expense | (979 | ) | 1 | (a) | (978 | ) | ||||||||
| Other non-operating income (expense), net | 8 | 8 | ||||||||||||
| Net income from continuing operations, before income taxes | 248 | (55 | ) | 193 | ||||||||||
| Income tax benefit (expense) | (67 | ) | 19 | (b) | (48 | ) | ||||||||
Net income from continuing operations | 181 | (36 | ) | 145 | ||||||||||
| Less: Net income attributable to noncontrolling interests | 368 | (3 | ) | (a) | 365 | |||||||||
Net loss attributable to Tenet Healthcare Corporation common shareholders | $ | (187 | ) | $ | (33 | ) | $ | (220 | ) | |||||
| Loss per share attributable to Tenet Healthcare Corporation common shareholders: | ||||||||||||||
| Basic | $ | (1.88 | ) | $ | (2.22 | ) | ||||||||
| Diluted | $ | (1.88 | ) | $ | (2.22 | ) | ||||||||
| Weighted average shares and dilutive securities outstanding (in thousands): | ||||||||||||||
| Basic | 99,321 | 99,321 | ||||||||||||
| Diluted | 99,321 | 99,321 | ||||||||||||
4
Tenet Healthcare Corporation
Unaudited Pro Forma Condensed Statement of Operations
For the Three Months Ended March 31, 2017
| (Dollars in millions except per share amounts) | Historical | Pro Forma Adjustments | Pro Forma | |||||||||||
| Net operating revenues: | ||||||||||||||
| Net operating revenues before provision for doubtful accounts | $ | 5,196 | $ | (182 | ) | (a) | $ | 5,014 | ||||||
| Less: Provision for doubtful accounts | 383 | (39 | ) | (a) | 344 | |||||||||
Net operating revenues | 4,813 | (143 | ) | 4,670 | ||||||||||
| Equity in earnings of unconsolidated affiliates | 29 | 29 | ||||||||||||
| Operating expenses: | ||||||||||||||
| Salaries, wages and benefits | 2,380 | (63 | ) | (a) | 2,317 | |||||||||
| Supplies | 765 | (18 | ) | (a) | 747 | |||||||||
| Other operating expenses, net | 1,187 | (45 | ) | (a) | 1,142 | |||||||||
| Electronic health record incentives | (1 | ) | (1 | ) | ||||||||||
| Depreciation and amortization | 221 | (6 | ) | (a) | 215 | |||||||||
| Impairment and restructuring charges, and acquisition-related costs | 33 | 33 | ||||||||||||
| Litigation and investigation costs | 5 | 5 | ||||||||||||
| Gains on sales, consolidation and deconsolidation of facilities | (15 | ) | (15 | ) | ||||||||||
| Operating income | 267 | (11 | ) | 256 | ||||||||||
| Interest expense | (258 | ) | (258 | ) | ||||||||||
| Other non-operating income (expense), net | (5 | ) | (5 | ) | ||||||||||
| Net income (loss) from continuing operations, before income taxes | 4 | (11 | ) | (7 | ) | |||||||||
| Income tax benefit (expense) | 33 | 4 | (b) | 37 | ||||||||||
| Net income from continuing operations | 37 | (7 | ) | 30 | ||||||||||
| Less: Net income attributable to noncontrolling interests | 89 | (1 | ) | (a) | 88 | |||||||||
| Net loss attributable to Tenet Healthcare Corporation common shareholders | $ | (52 | ) | $ | (6 | ) | $ | (58 | ) | |||||
| Loss per share attributable to Tenet Healthcare Corporation common shareholders: | ||||||||||||||
| Basic | $ | (0.52 | ) | $ | (0.58 | ) | ||||||||
| Diluted | $ | (0.52 | ) | $ | (0.58 | ) | ||||||||
| Weighted average shares and dilutive securities outstanding (in thousands): | ||||||||||||||
| Basic | 100,000 | 100,000 | ||||||||||||
| Diluted | 100,000 | 100,000 | ||||||||||||
5
Notes to Unaudited Pro Forma
Condensed Statement of Operations
| (a) | Eliminates the historical revenue and operating expenses of the divested Houston-area hospitals and related facilities. |
| (b) | Reflects the applicable income tax effects of the pro forma adjustments in this column at an effective tax rate of 37%, which includes the federal statutory rate of 35% plus applicable state taxes, adjusted for nondeductible expenses. |
6